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Introduction 54
Hemorrhagic cystitis is a serious and difficult to manage complication resulting from exposure to certain 55 chemotherapeutic agents (1-4), radiation therapy (4-7) and various viruses in immunosuppressed patients (8-56 11) . Indeed, anticancer doses of oxazaphosphorines, such as cyclophosphamide and ifosfamide, are limited in 57 part due to the risks of this complication (1-3). In the case of these agents, hepatic drug metabolism generates 58 toxic acrolein which accumulates in bladder urine (12, 13) . Fortunately, risks of chemotherapy-induced 59
There is a significant need for additional approaches to prevent and treat chemotherapy-induced hemorrhagic 85 cystitis. Several analogs of cyclophosphamide that may enhance cytostatic efficacy while limiting urotoxicity 86 have been explored, albeit with limited success (13, 39, 40) . Candidate drugs targeting the inflammatory 41) and/or promoting oxidative stress responses show promise for ameliorating 88 hemorrhagic cystitis but have not progressed beyond preclinical testing. Most efforts have been focused towards 89 finding alternatives to MESNA, including anti-inflammatory molecules (42) (43) (44) (45) (46) (47) (48) (49) , hemostatic agents (50-52), 90 antioxidants (37, 48, 49, (53) (54) (55) (56) (57) (58) (59) , analgesics (60), anti-depressants (61), vasodilator (62), cytokines (25, 63, 64) , 91 platelet rich plasma (65, 66) , nutritional approaches (67, 68), and plant extracts (45, 46, 48, 56, (68) (69) (70) (71) . These 92 4 early-stage drug candidates target pro-inflammatory pathways, heme homeostasis pathway and anti-oxidant 93 homoeostasis. 94
Another potential approach to treat chemotherapy-induced hemorrhagic cystitis is to administer IL-4 (25), a 95 potent anti-inflammatory cytokine known to antagonize the IL-1β, TNFα, and IL-6 pathways. This finding led 96 us to test and verify that a single dose of an IL-4-inducing, parasite-derived anti-inflammatory molecule (IPSE, 97 the IL-4-inducing principle from Schistosoma mansoni eggs) ameliorated the inflammation, hemorrhage, and 98 urothelial sloughing associated with ifosfamide-induced hemorrhagic cystitis (42) . IPSE binds 99 immunoglobulins, notably IgE on the surface of basophils and mast cells, inducing secretion of preformed IL-4 00 (72) (73) (74) . However, we suspect IPSE may have additional mechanisms underpinning its ability to alleviate 01 ifosfamide-induced hemorrhagic cystitis. IPSE also sequesters chemokines (75), which likely orchestrate anti-02 inflammatory responses. As an infiltrin possessing a nuclear localization sequence (NLS), IPSE is able to 03 translocate into host cell nuclei to modulate host gene transcription (76) (77) (78) . Given that the transcriptional 04 changes during ifosfamide-induced hemorrhagic cystitis are largely unknown, and because the underlying 05 mechanisms of IPSE's protective effects remain to be elucidated, we undertook transcriptome-wide profiling of 06 the bladder of ifosfamide-treated mice using RNA-Seq. Furthermore, we studied the gene expression dynamics 07 in IPSE pretreated mice challenged with ifosfamide. Here, we show that key pro-inflammatory, heme 08 homeostatic and oxidative stress response pathways are highly activated in the bladder following ifosfamide 09 insult. Finally, we show that IPSE downregulates pro-inflammatory responses as a potential protective 10 mechanism, in addition to its involvement in promoting urothelial repair. 11 12 Results 13
Ifosfamide-induced hemorrhagic cystitis is ameliorated by IPSE 14
We recently showed that a single dose of IPSE was comparable to administration of recombinant IL-4 or three 15 doses of MESNA in alleviating ifosfamide-induced hemorrhagic cystitis (42). We used these established 16 methods to obtain bladder samples for transcriptional profiling. Mice were administered: 1) saline or 2) IPSE, 17 24 hours before ifosfamide challenge, or 3) saline vehicle alone. Twelve hours following ifosfamide insult, 18 bladder histopathology was analyzed in a blinded fashion. Compared to bladders from saline-treated mice (Fig. 19 1A), bladders from mice challenged with ifosfamide showed marked edema, dysregulated contraction, 20 hemorrhage, and urothelial sloughing ( Fig. 1B and D) . Conversely, bladders from mice treated with IPSE 21 before ifosfamide challenge were significantly protected from urothelial denudation and inflammation (Fig. 22 1C). Based on blinded scoring of bladder sections, we observed significant increases in inflammation ( Fig. 1E ), 23 5 urothelial denudation (Fig. 1F ), and edema (Fig. 1G) , and non-statistically significant increases in hemorrhage 24 ( Fig. 1H ) in ifosfamide-treated mice. These features were markedly reduced in mice administered a single dose 25 of IPSE before ifosfamide treatment, in comparison to ifosfamide-treated mice. Both inflammation and 26 urothelial denudation were significantly reduced ( Fig. 1E and F) , while edema and hemorrhage were reduced 27 but not statistically significant ( Fig. 1G and H Ifosfamide is metabolized in the liver to generate acrolein, which is secreted in urine and damages the bladder 45 (18). To understand the transcriptional alterations elicited by acrolein in the bladder during ifosfamide-induced 46 hemorrhagic cystitis, mice were treated with saline vehicle or ifosfamide. Gene expression dynamics in the 47 ifosfamide-injured bladder were studied through RNA-Seq performed on bladders harvested 6 hours following 48 ifosfamide injection. RNA sequencing was performed to a considerable depth (20 million reads), more than 49 96% of which were successfully aligned to the Mus musculus genome. Principal component analysis indicated 50 gene expression homogeneity among ifosfamide-treated bladders relative to the vehicle control ( Fig. 2A ) and a 51 slight overlap between bladders from ifosfamide-treated mice and IPSE pretreated mice challenged with 52 ifosfamide (Fig. 2B ). Volcano plotting of differentially expressed genes and their associated statistical 53 significance ( Fig. 2C ) revealed upregulation of a large set of genes (n = 2061) and downregulation of an 54 appreciable number of genes (n = 1114), based on p-value (adjusted) < 0.1 and log2(Fold Change) > 1 (at least 55 2-fold). Among the top upregulated genes were Il6, a major member of the IL-1ߚ, TNFߙ and IL-6 pro-56 inflammatory triad. These three cytokines together are major drivers of inflammatory responses (see 57 relationship with other downstream proinflammatory genes, regulators and mediators in Fig. 2D ). Indeed, the 58 Il1b, Tnfa and Il6 genes were upregulated by about two orders of magnitude. The Ptx3 gene was also one of the 59 top upregulated genes; a member of the pentraxin protein family, major components of the humoral arm of 60 innate immune response highly induced in response to inflammatory stimuli (79). Chemokines were also highly 61 upregulated, especially Cxcl2 and Ccl2. In addition, the Hmox1 gene encoding the heme oxygenase 1 enzyme, 62 the first enzyme of the heme oxygenase pathway, was also highly upregulated. The Eid3 gene, also among the 63 most upregulated genes, is involved in cellular responses to stress ( Fig. 2C and Supplementary Fig. S1 ). The 64 cysteine transporter, Slc7a11, which has been implicated in glutathione metabolism in the bladder (80, 81), was 65 also significantly upregulated in ifosfamide-injured bladders (Fig. 2C ). 
Pathway and functional analysis expectedly revealed signatures of inflammation. Specifically, there was 81 differential activity involving the IL-6 pathway, in which IL-1ߚ, TNFߙ and IL-6 play major roles, and other 82 pro-inflammatory pathways implicated in the pathogenesis of ifosfamide-induced hemorrhagic cystitis (35, 41, 83 47, 82-84) (Fig. 2C, Fig. 3 and Supplementary Fig. S1 ). IL-6 and its cognate receptors were highly upregulated, 84 in addition to STAT3 and the tyrosine protein kinase JAK2, which are both involved in IL-6 signaling ( Fig. 4A  85 and Supplementary Fig. S2A ). Similarly, IL-1ߚ, TNFߙ and their receptors were upregulated. These cascades 86 converge through TAK1 to promote formation of the IߢB-NFߢB complex and drive pro-inflammatory gene 87 transcription in conjunction with NF-IL-6, the nuclear factor of IL-6 expression ( Fig. 4A and Supplementary 88 Fig. S2B ). Accordingly, the STAT3 and NFߢB pathways, both major drivers of inflammation and immune 89 response via the IL-1ߚ-TNFߙ-IL-6 triad, were upregulated following ifosfamide insult transcription 90 ( Supplementary Fig. S2A and B). Other major upregulated pro-inflammatory pathways and disease signaling 91 cascades included those related to TNF receptor, iNOS, the acute phase response, diabetes mellitus, HMGB1, 92 oncostatin, generation of ROS and RNS, and major innate immune-related cascades ( Fig. 3 ). Finally, there was 93 noteworthy upregulation of the IL-17F-mediated allergic inflammatory and leukocyte extravasation signaling 94 pathways ( Supplementary Fig. S3 ). 95 9 96
Fig. 3. Most differentially altered gene pathways in the bladder during ifosfamide-induced hemorrhagic 97

cystitis. Functional comparison of the transcriptome of bladders from ifosfamide-versus vehicle-treated mice 98
was performed using Ingenuity Pathway Analysis. Bars are colored according to z-score, with red showing 99 upregulation and blue denoting downregulation. The size of each bar is proportional to its -log(p-value Another hallmark of ifosfamide-induced hemorrhagic cystitis is a significant oxidative stress response to 16 acrolein exposure and resulting hemorrhage (33). Our data underscores a major role for the erythroid-derived 17 leucine zipper NRF2 as a nuclear factor involved in regulating oxidative stress responses to ifosfamide injury of 18 the bladder (37, 51, 53) ( Fig. 3, 5A and Supplementary Fig. S4 ). The NRF2-mediated oxidative stress response 19 gene pathway, which regulates the expression of antioxidant and heme homeostatic proteins, was one of the 20 most upregulated pathways in the bladder following ifosfamide insult (Fig. 3, 5A and Supplementary Fig. S4 ). 21
We noted considerable upregulation of genes encoding enzymes including heme oxygenase (HO-1), which 22 catalyzes the first step in heme homeostasis, the antioxidant thioredoxin reductase (TRXR1), which catalyzes 23 the reduction of thioredoxin to restore redox homeostasis, peroxiredoxin (PRDX1), which detoxifies peroxide 24 radicals, and glutathione reductase (GSR), which reduces glutathione disulfide to glutathione, an important 25 antioxidant that scavenges hydroxyl radicals. Also upregulated were thioredoxin (TXN), superoxide dismutase 26 (SOD) and ferritin light and heavy chain proteins (FTL and FTH1), which are involved in redox signaling, 27 superoxide partitioning and iron homeostasis, respectively (Fig. 5A ). Genes encoding proteins involved in 28 xenobiotic detoxification were also upregulated in response to acrolein (Fig. 5A ). In addition, the p38 MAPK 29 pathway, implicated in responses to stress stimuli (43), was also substantially upregulated. 30 31
Fig. 5. Oxidative stress responses of the bladder during ifosfamide-induced hemorrhagic cystitis. (A) 32
Schematic representation of the relationships between NRF2 and antioxidant proteins and proteins involved in 33 heme homeostasis and xenobiotic detoxification. A more detailed version is shown in Supplementary Fig. S4 . 34
The keys to the shapes and colors are as detailed in Fig. 4. (B) Heat map showing levels of expression of genes 35 encoding major antioxidant enzymes. There were no overt changes in the levels of expression of these genes, 36 except for Fth1, Ftl1, Abcc1, Gclc, Gclm, Gm3776 and to some extent for Gsr, Sod2 and Dnajb1. Red 37 designates gene upregulation while blue denotes downregulation. The columns represent data for individual 12 mice in each treatment group ("Sal": saline vehicle treatment, "Ifos": ifosfamide treatment only, "Ipse": 39 ifosfamide and IPSE treatment) . 40
41
The most downregulated pathway in the ifosfamide-exposed bladder was the peroxisome proliferator-activated 42 receptor (PPAR) signaling pathway, which is involved in lipid homoeostasis (85), in addition to its anti-43 inflammatory effect (86, 87) and role in the development and maintenance of IL-4 dependent alternatively 44 activated status in macrophages (88) ( Fig. 3 and Supplementary Fig. S5 ). TWEAK, Wnt and Hedgehog, which 45
can mediate anti-inflammatory responses, were likewise downregulated (Fig. 3) . The aldosterone signaling in 46 epithelial cells pathway, which is involved in ion transport to maintain electrolyte and water balance across 47 epithelial surfaces, was also downregulated (Fig. 3) . Finally, analysis of diseases and functions affected by 48 bladder ifosfamide challenge showed considerable upregulation of functions related to organismal injury and 49 abnormalities, inflammatory diseases, cancer, cell proliferation, cellular movement and hematological 50 development and function ( Supplementary Fig. S6 ). There was also notable upregulation of genes and 51 regulators in the neuro-inflammatory pathways ( Supplementary Fig. S7 ). Analysis of differentially expressed 52 gene members of neuro-inflammatory pathways indicated significant expression of genes encoding 53 proinflammatory cytokines and mediators in neuronal cells. Although this may suggest role in the acrolein-54 associated hyperalgesia, the presence of astrocytes or microglia in the peripheral nervous system within the 55 bladder is unproven ( Supplementary Fig. S7 ). Finally, the HIF-1ߙ-mediated hypoxia-related signaling cascade, 56 was upregulated in the bladder after ifosfamide insult, consistent with the hemorrhage associated with 57 hemorrhagic cystitis ( Supplementary Fig. S8 ). 58
59
Transcriptional modulatory effects of IPSE on the ifosfamide-exposed bladder 60 We recently reported that IPSE, an immunomodulatory protein of parasite origin, can ameliorate much of the 61 pathology associated with ifosfamide-induced hemorrhagic cystitis ((42) and Fig. 1 ). To provide insight into the 62 underlying mechanisms of the IPSE's protective effects, we undertook gene expression profiling of the 63 ifosfamide-challenged bladder, with or without IPSE pretreatment. Mice were treated with saline or IPSE, 24 64 hours before challenge with ifosfamide. Gene expression dynamics were profiled through RNA-Seq analysis of 65 bladders harvested 6 hours following ifosfamide administration. Compared to mice receiving ifosfamide 66 without IPSE pretreatment, genes encoding cytokines driving pro-inflammatory responses (IL-1ߚ, TNFߙ and 67 IL-6 triad) were downregulated 50% in the bladders of mice treated with IPSE before ifosfamide challenge (Fig.  68   4B ). Similar downward trends in gene expression were observed for these cytokine's receptors and downstream 69 13 genes and other genes and transcriptional factors driving inflammation ( Fig. 4B and 6A ). The expression of 70 Cxcl10 (IP-10), a major interferon gamma-induced chemokine, was highly increased in ifosfamide-injured 71 bladders but downregulated in the bladders of IPSE-pretreated, ifosfamide-exposed mice (Fig. 6A) . The 72 transcriptional levels of several other chemokines also involved in inflammatory responses and recruitment of 73 cells to sites of stress were highly upregulated in bladders only exposed to ifosfamide, but conversely 74 downregulated in ifosfamide-injured bladders pretreated with IPSE (Fig. 6A) . The predicted gene interaction 75 grids associated with IPSE administration featured a network linking downregulation of Ccl2 (and other 76 chemokines genes) to the downregulation of a number of gamma interferon-inducible proteins and nitric oxide 77 synthase ( Fig. 6B and Supplementary Fig. S9 ). Other mechanistic networks suggesting IPSE induced 78 downregulation of additional pro-inflammatory factors were also noted ( Supplementary Fig. S9 ). 79 80 
Fig. 6. Effects of IPSE on bladder transcription of inflammation-related genes during ifosfamide-induced
14 mechanistic network showing inhibitory relationships among chemokines (Ccl2), nitric oxide synthase and 88 several interferon-induced proteins. The keys to the shapes and colors are as detailed in Fig. 4 . 89
90
The most downregulated gene pathway (in terms of statistical significance) in the bladders of IPSE-pretreated, 91 ifosfamide-exposed mice, compared to bladders exposed only to ifosfamide, was the interferon signaling 92 pathway (Fig. 7) . Many of the major gene pathways noted to be highly upregulated in ifosfamide-damaged 93 bladders were relatively downregulated in bladders pretreated with IPSE before ifosfamide challenge ( Fig. 3  94 and 7). These downregulated pathways included those related to interferon signaling, inflammatory diseases 95 such as osteoarthritis and diabetes mellitus, pattern recognition receptor signaling pathways of the innate 96 immune system, pro-inflammatory pathways including NFߢB, iNOS, neuro-inflammation, TREM1, the acute 97 phase response, HMGB1, STAT3, IL-6, TNFR, IL-1 and pathways involved in the production of ROS and RNS 98 ( Fig. 7) . We also observed a relative increase in metabolic gene expression relevant to oxidative 99 phosphorylation, glycolysis and PPAR signaling. Interestingly, the most downregulated genes in terms of z-00 score were those related to the neuro-inflammation signaling pathway (astrocytes and microglia). While a direct 01 effect of IPSE on bladder neurons could not be inferred based on this finding, due to a lack of astrocytes and 02 microglia in the bladder, we have observed significant reduction in bladder pain in IPSE-treated mice 03 challenged with ifosfamide (42). 04 15 05
Fig. 7. Most differentially altered gene expression pathways in bladders from IPSE-pretreated mice 06
challenged with ifosfamide. Mice were pretreated with saline or IPSE, 24 hours before challenge with 07 400mg/kg of ifosfamide. The bladders were subjected to transcriptional profiling (RNA-Seq) and functional 08 analysis using Ingenuity Pathway Analysis. Bars are colored according to z-score, with red showing 09 upregulation and blue denoting downregulation. The size of each bar is proportional to its -log(p-value) . 10 Compared to bladders pretreated with IPSE before ifosfamide insult, bladders exposed only to ifosfamide 12 relatively upregulated gene expression of some antioxidant enzymes, including Fth1, Ftl1, Abcc1, Gclc, Gclm, 13 Gm3776 and to some extent for Gsr, Sod2 and Dnajb1 (Fig. 5B) . It is notable that the downregulated gene 14 expression of proteins in this pathway were those involved in DNA damage sensing, superoxide partitioning 15 and detoxification of xenobiotics, and metal ion homeostasis (Fig. 5B) . In particular, relatively lower expression 16 of genes encoding the ferritin proteins (Fth1 and Ftl1) suggest relatively earlier restoration of iron homeostasis 17 in IPSE pretreated mice, supporting the observed decrease in bladder hemorrhage induced by IPSE pretreatment 18 before IFS challenge (42). Taken together, these data suggest in IPSE-pretreated bladders exposed to 19 ifosfamide, that there is a significant anti-oxidant response following accumulation of acrolein, but lower 20 expression of genes related to detoxification of xenobiotics, DNA damage sensing and iron homeostasis. 21
22
Discussion 23
Herein we describe the first transcriptome-wide profiling of the bladder during ifosfamide-induced hemorrhagic 24 cystitis. To accomplish this, we used a tractable mouse model which recapitulates the pathogenesis of 25 hemorrhagic cystitis (25) resulting from the urotoxic effect of acrolein, a byproduct of ifosfamide metabolism. 26
This study has verified a number of important findings regarding specific biological aspects of ifosfamide-27 induced hemorrhagic cystitis. We have expanded upon this body of work by defining multiple key pathogenetic 28 mechanisms through comprehensive transcriptomics. Furthermore, our RNA-Seq data extends our prior work 29 on the therapeutic effect of IPSE in ifosfamide-induced hemorrhagic cystitis (42). This study has revealed a 30 central role played by the IL-1ߚ, TNFߙ and IL-6 triad in driving the substantial inflammation associated with 31 ifosfamide-induced hemorrhagic cystitis (35, 41, 47, (82) (83) (84) . A 100-fold increase in expression of IL-1ߚ, TNFߙ 32 a n d I l -L -6
was reduced ~50% by pretreatment with a single dose of IPSE. We also confirmed that gene 33 members of the heme hemostasis and oxidative stress response biological systems were highly transcribed 34 following ifosfamide-induced hemorrhagic cystitis, presumably to restore antioxidants to normal levels (37, 48, 35 50-53, 56-58) . Moreover, we have shown that these urotoxicity-associated transcriptional changes, especially 36 inflammatory responses, were downregulated by IPSE when administered before ifosfamide challenge. 37
Unlike MESNA, which binds to and neutralizes acrolein directly to prevent urotoxicity, IPSE prevents or 38 reverses the inflammatory changes that drive bladder damage following ifosfamide exposure. We postulate that 39 IPSE, through its inhibitory transcriptional effects on IL-1ߚ, TNFߙ and IL-6, key upstream cytokines driving 40 inflammation via NFߢB and STAT3, limits ifosfamide-triggered inflammation, urothelial denudation and 41 17 vascular pathogenesis. The ability of IPSE to induce gene expression of uroplakins (42), crucial urothelial 42 barrier function genes, is a likely contributor to IPSE's therapeutic effect on the bladder following chemical 43 insult (59, 89, 90) . Other candidate drugs for ifosfamide-induced hemorrhagic cystitis have also been shown to 44 specifically target the IL-1ߚ-TNFߙ-IL-6 pathway. Dantas et al. (2010) showed that simvastatin attenuated 45 cyclophosphamide-induced urothelial inflammation by decreasing the expression and activities of IL-1ߚ, TNFߙ 46 and IL-6 (47). Recombinant IL-4, quinovic acid glycosides, oleuropein, anakinra, pentoxifylline, diallyl 47 disulfide and other anti-inflammatory candidates were separately shown to reduce the pathogenesis of 48 hemorrhagic cystitis by inhibition of the expression of these inflammatory cytokines and their receptors (25, 41, 49 43, 45, 48, 49) . In accord with our observations, other drug studies have identified a therapeutic requirement for 50 downregulation of IL-1ߚ, TNFߙ and IL-6 associated transcriptional factors (NFߢB and STAT3) (32, 43) and 51 downstream inflammatory mediators (iNOS and COX-2) (25, 32, 48, 83, 84, 91, 92) . 52
Besides effects on the IL-1ߚ, TNFߙ and IL-6 triad, IPSE may also mediate critical gene expression changes in 53 chemokines in ifosfamide-induced hemorrhagic cystitis. A range of major chemokines genes (Ccl2, Ccl3, Ccl4, 54 Ccl5, Ccl7, Ccl12, Cxcl1, Cxcl2, Cxcl3, Cxcl5, Cxcl10 and Cxcl13) acting as chemo-attractants to site of stress 55 were significantly downregulated by IPSE pretreatment before ifosfamide insult. For instance, Cxcl10 56 transcription is upregulated in the bladder following ifosfamide insult, and is significantly decreased by 57 comparison in IPSE-pretreated, ifosfamide-exposed bladders. Indeed, CXCL10 blockade has been shown to 58 significantly dampen cyclophosphamide-induced hemorrhagic cystitis (93). Interleukin 8 receptor (Cxcr2) was 59 also relatively downregulated by IPSE pretreatment before ifosfamide challenge. Notably, Cxcr2 was 60 previously identified to play an important role in cyclophosphamide induced hemorrhagic cystitis (94). 61 IPSE likely orchestrates a portion of its therapeutic effects through actions on other cytokines. Gene expression 62 network analysis revealed a link between the observed downregulation of CCL2 in the bladders of IPSE-63 pretreated, ifosfamide-challenged mice (versus the bladders from mice receiving only ifosfamide) and several 64 gamma interferon-inducible proteins. Also, the interferon signaling pathway was the most downregulated 65 pathway in the bladders of IPSE-pretreated mice as compared to bladders only exposed to ifosfamide. Our 66 results point to an association between downregulation of the interferon signaling pathway and amelioration of 67 acrolein-induced urotoxicity, a mechanism that has not been previously linked to protection from hemorrhagic 68 cystitis. The interferon signaling pathway has been previously shown to cross-talk with inflammasomes 69 activated during inflammatory responses to irritants (95, 96) . Some of these gamma interferon inducible genes 70 are in turn linked to the development of pyroptosis, a highly inflammatory form of programmed cell death (Fig.  71   6B ). Acrolein-induced pyroptotic cell death is a major determining factor of the severity of ifosfamide-induced 72 urotoxicity (12, 32, 59) . Pyroptosis can be compounded by activation of the inflammasome complex, which 73 generates reactive species which perpetuate a vicious cycle of cell death (34, 36) . The ability of IPSE to 74 18 downregulate the interferon pathway, in conjunction with downregulation of major inflammatory pathways, 75 may limit inflammasome activation and thus reduce acrolein-induced pyroptotic cell death. We hypothesize that 76 IPSE, by bringing these processes to heel, subsequently modulates downstream urothelial damage, hemorrhage, 77 oxidative stress and cellular infiltration. 78
The therapeutic efficacy of IPSE in ifosfamide-induced hemorrhagic cystitis may also partially depend on its 79 modulation of oxidative stress cascades. Acrolein is a potent inducer of oxidative stress (33). Indeed, the NRF2-80 mediated oxidative stress responses pathway, which restores heme homeostasis and antioxidant responses, was 81 highly expressed in the setting of ifosfamide-induced hemorrhagic cystitis (37). Accordingly, Hmox1 and 82
Slc7a11 were among the top upregulated genes from this transcriptomic analysis. Slc7a11 is a cysteine 83 transporter, which has been implicated in glutathione metabolism in the bladder (80, 81) . NRF2 induces the 84 expression of heme oxygenase 1 (HO-1), the first enzyme of the heme oxygenase pathway, and several 85 antioxidant enzymes including glutathione reductase (GSR), thioredoxin (TXN), thioredoxin reductase 86 (TRXR1), superoxide dismutase (SOD), peroxiredoxin 1 (PRDX1), ferritin light chain (FTL) and ferritin heavy 87 chains (FTH) (38) . An association between an increase in the expression of NRF2 and protection from 88 ifosfamide-induced hemorrhagic cystitis is consistent with a previous report linking hemostasis to reduction in 89 hemorrhagic cystitis (37, 51, 53) . In addition, there is a strong pathophysiological relationship between 90 inflammation and oxidative stress (97). Severe pyroptosis can lead to enzymatic tissue damage and cellular 91 DNA damage, which generate reactive species and superoxide radicals that induce oxidative stress (12, 97) . 92
When the bladder vasculature is exposed and injured following inflammation-driven urothelial damage, the 93 resulting hemorrhage and release of heme further promotes oxidative stress. Based on the rationale that limiting 94 inflammation reduces oxidative stress, and restoration of oxidative homeostasis initiates tissue repair processes, 95 hemostatic agents and antioxidants have been widely tested as alternative therapies for preventing or reducing 96 ifosfamide-induced hemorrhagic cystitis (37, (48) (49) (50) (51) (52) (53) (54) (55) (56) (57) (58) (59) . The link between inflammation and oxidative stress is 97 evident from findings that most antioxidants showing efficacy in ifosfamide-induced hemorrhagic cystitis also 98 downregulate pro-inflammatory cytokines and their downstream mediators (53, 56, 58, 61) . In the same vein, 99 anti-inflammatory drug candidates with efficacy in ifosfamide-induced hemorrhagic cystitis can also restore 00 antioxidant enzyme activity to homoeostatic levels (43, 48, 49) . In this study, however, we did not observe overt 01 differential transcriptional changes in oxidative stress responses induced by IPSE pretreatment, although some 02 antioxidant enzymes in bladders of IPSE-treated mice returned to basal levels. Nevertheless, it was interesting 03 to observe that the genes encoding the proteins involved in iron homeostasis (Fth and Ftl) were relatively 04 restored to baseline in bladders from the IPSE treated group. Also, some antioxidant proteins involved in 05 xenobiotic detoxification and hemostasis (Gclm, Gclc, Gsr and Gm3776), superoxide detoxification (Sod2) and 06 stress induced chaperones (Stip1 and Dnajb1) were also reduced to normal levels in bladders from the IPSE-07 19 pretreated group. In addition, multidrug resistance protein 1 (Abcc1, Mrp1), which functions as an anion 08 transporter with glutathione as a substrate (98), returned to basal levels in the ifosfamide-exposed bladder 09 following IPSE pretreatment. Taken together, these differences suggest reduced levels of oxidative stress are 10 present in ifosfamide-exposed bladders from IPSE-pretreated group, evident in reduced levels of genes related 11 to detoxification of xenobiotics, DNA damage sensing and iron homeostasis. 12
Ifosfamide injury of the bladder may disrupt homeostasis of pathways besides oxidative stress. The PPAR 13 pathway was downregulated in the ifosfamide-exposed bladder, which would presumably impair restoration of 14 lipid homeostasis following epithelial membrane damage by acrolein. The PPAR pathway is also a modulator of 15 inflammatory responses (86, 87) in addition to its role in the development and maintenance of IL-4 dependent 16 alternatively activated status in macrophages (88), which we speculate may be inhibited in the highly 17 inflammatory environment of the ifosfamide-injured bladder. Interestingly, we did not observe any significant 18 effects of IPSE pretreatment on transcription of gene members of the PPAR pathway, suggesting a post-19 translational mechanism not captured by our early time point. In contrast, the most IPSE-downregulated genes 20 in the ifosfamide-exposed bladder were those related to the neuro-inflammation signaling pathway (specifically, 21 pathways active in central nervous system cells, i.e., astrocytes and microglia). We have previously reported 22 that IPSE alleviates ifosfamide-induced allodynia (42). It remains to be shown whether this observed 23 downregulation of neuro-inflammatory signaling is directly linked to this protective effect on allodynia, 24 especially given the absence of astrocytes and microglia in the bladder. 25
While this study has revealed potential mechanistic changes associated with ifosfamide-induced hemorrhagic 26 cystitis, and presented evidence of possible underlying mechanisms of IPSE's therapeutic effect, our RNA-Seq-27 based approach cannot establish a causal relationship between observed gene expression and phenomena of 28 interest (including IPSE's therapeutic effects). This dataset did not reveal whether the therapeutic effects of 29 IPSE are due to its IL-4-inducing properties, chemokine sequestration, or nuclear translocation-related, direct 30 transcriptional effects. For instance, the downregulation of interferon signaling and its related genes is 31 intriguing, but it is unclear to which extent this can be ascribed to IPSE-induced IL-4. Also, RNA-Seq does not 32 capture epigenetic or post-translational regulation of gene or protein expression and activity. Moreover, we 33 focused on a single, early time point following ifosfamide exposure. Although we observed differential 34 transcription of multiple genes of interest at this time point, it is unlikely that this cross-sectional analysis has 35 captured all relevant gene expression. Finally, this study focused on transcriptional changes in the bladder 36 alone, and did not examine systemic gene expression induced by ifosfamide and IPSE. It is possible that such 37 gene expression may account for some of ifosfamide and IPSE's in vivo effects. 38 20 In conclusion, we have elucidated transcriptional dynamics associated with ifosfamide-induced hemorrhagic 39 cystitis. These data provide new insights into the underlying mechanisms driving acrolein-induced urotoxicity 40 associated with the use of ifosfamide and other oxazaphosphorines. We also showed that IPSE, an anti-41 inflammatory, parasite-derived molecule with therapeutic potential for ifosfamide-induced hemorrhagic cystitis 42 (42), downregulates major inflammatory pathways potentially related to its mechanisms of effect. Our work 43 demonstrates that there may be therapeutic potential for naturally occurring anti-inflammatory molecules, 44
including pathogen-derived factors, as alternative or complementary therapies for ifosfamide-induced 45 hemorrhagic cystitis. Apart from inhibition of inflammation and modest restoration of normal levels of 46 antioxidants, we did not observe complete prevention of acrolein-induced oxidative stress by IPSE 47 pretreatment. This is probably due to IPSE's inability to directly bind to and neutralize acrolein (the mechanism 48 of MESNA). Thus, IPSE is playing only a limited role on oxidative stress while suppressing inflammation. 49 However, we have only compared one dose of IPSE given before ifosfamide challenge against three doses of 50 MESNA. It remains to be shown whether IPSE will produce more ameliorative effects when given in multiple 51 doses or through alternative routes. Ongoing work is focusing on optimization of IPSE, specifically related to its 52 IL-4 induction and chemokine binding properties, to enhance its efficacy while preventing toxicity. Our hope is 53 that these variations on IPSE and its administration will result in significantly improved efficacy, and 54 ultimately, an alternative to MESNA in preventing ifosfamide-induced hemorrhagic cystitis. 
